A detailed history of Geode Capital Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Geode Capital Management, LLC holds 100,652 shares of BNTX stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,652
Previous 101,499 0.83%
Holding current value
$11.4 Million
Previous $8.16 Million 46.57%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$78.36 - $124.66 $66,370 - $105,587
-847 Reduced 0.83%
100,652 $12 Million
Q2 2024

Aug 09, 2024

BUY
$80.36 - $102.87 $730,392 - $934,985
9,089 Added 9.84%
101,499 $8.16 Million
Q1 2024

May 13, 2024

BUY
$88.96 - $112.35 $176,407 - $222,790
1,983 Added 2.19%
92,410 $8.52 Million
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $214,729 - $266,315
2,362 Added 2.68%
90,427 $9.54 Million
Q3 2023

Nov 13, 2023

BUY
$98.5 - $125.08 $122,632 - $155,724
1,245 Added 1.43%
88,065 $9.57 Million
Q2 2023

Aug 11, 2023

BUY
$102.58 - $129.66 $257,270 - $325,187
2,508 Added 2.97%
86,820 $9.37 Million
Q1 2023

May 15, 2023

BUY
$122.57 - $153.67 $120,118 - $150,596
980 Added 1.18%
84,312 $10.5 Million
Q4 2022

Feb 13, 2023

BUY
$118.43 - $186.05 $458,324 - $720,013
3,870 Added 4.87%
83,332 $12.5 Million
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $277,255 - $397,714
2,172 Added 2.81%
79,462 $10.7 Million
Q2 2022

Aug 12, 2022

BUY
$123.25 - $186.24 $1.39 Million - $2.1 Million
11,250 Added 17.04%
77,290 $11.5 Million
Q1 2022

May 13, 2022

BUY
$126.25 - $231.85 $19,947 - $36,632
158 Added 0.24%
66,040 $11.3 Million
Q4 2021

Feb 11, 2022

BUY
$216.64 - $362.52 $1.51 Million - $2.52 Million
6,958 Added 11.81%
65,882 $17 Million
Q3 2021

Nov 12, 2021

BUY
$205.93 - $447.23 $383,029 - $831,847
1,860 Added 3.26%
58,924 $16.1 Million
Q2 2021

Aug 13, 2021

BUY
$113.32 - $241.49 $147,769 - $314,902
1,304 Added 2.34%
57,064 $12.8 Million
Q1 2021

May 12, 2021

BUY
$85.73 - $119.5 $654,548 - $912,382
7,635 Added 15.86%
55,760 $6.09 Million
Q4 2020

Feb 12, 2021

BUY
$72.71 - $129.54 $594,622 - $1.06 Million
8,178 Added 20.47%
48,125 $3.92 Million
Q3 2020

Nov 13, 2020

BUY
$57.81 - $104.17 $1.93 Million - $3.48 Million
33,361 Added 506.54%
39,947 $2.77 Million
Q2 2020

Aug 13, 2020

BUY
$38.58 - $66.74 $20,833 - $36,039
540 Added 8.93%
6,586 $439,000
Q1 2020

May 14, 2020

BUY
$28.55 - $92.0 $172,613 - $556,232
6,046 New
6,046 $353,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.